Waltham, MA, United States of America

Rongxin Shi

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Rongxin Shi

Introduction

Rongxin Shi is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of parathyroid hormone variants. With a total of 2 patents to his name, his work has the potential to impact the treatment of various medical conditions.

Latest Patents

Rongxin Shi's latest patents focus on parathyroid hormone (PTH) variants and their pharmaceutical compositions. These inventions relate to PTH compositions that exhibit improved serum half-life and peak-trough ratios. Furthermore, they provide methods for controlling serum calcium levels using these PTH variants and compositions. His work also includes methods for treating hypoparathyroidism and/or hypocalcemia due to hypoparathyroidism, showcasing the therapeutic potential of his innovations.

Career Highlights

Throughout his career, Rongxin Shi has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Shire-NPS Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Rongxin Shi has collaborated with several professionals in his field, including Clark Qun Pan and Angela Norton. These collaborations have likely enriched his research and development efforts, leading to advancements in his patented technologies.

Conclusion

Rongxin Shi's contributions to the field of pharmaceuticals, particularly through his patents on parathyroid hormone variants, demonstrate his commitment to innovation in medical treatments. His work has the potential to significantly improve patient care and outcomes in conditions related to calcium regulation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…